Total Credits: 1 including 1 AOA Category 1-A Credit(s)
Alzheimer’s disease continuum is a progression of symptoms that includes the cognitively normal phase, mild cognitive impairment (MCI), and various stages of Alzheimer’s dementia. Some treatment options for Alzheimer's disease include oral symptom management medications and newer anti-amyloid targeting therapies. Primary care providers can help identify patients who may benefit from anti-amyloid therapies. Imaging or newer blood-based biomarkers can help identify patients most likely to benefit. Pretreatment evaluations can also help identify candidates with acceptable risk for adverse events.
Objectives for The Future of Biomarkers and Personalized Treatments for Alzheimer’s and other Dementias
Dr. Shah is an advisor/consultant for Eli Lilly and Eisai, and part of the Speakers' Bureau for Eisai and Eli Lilly.
The Iowa Osteopathic Medical Association is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
IOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be put in writing and forwarded to IOMA Executive Director at ioma@ioma.org or IOMA, 6919 Vista Drive, West Des Moines, IA 50266.
| The Future of Biomarkers and Personalized Treatments for Alzheimer’s and other Dementias Slides (1.3 MB) | 18 Pages | Available after Purchase |
Dr.Yogi Shah is the Chief Medical Officer and Vice President of Medical Affairs for Broadlawns Medical Center. Dr. Shah joined the organization in September 2016 and served as a geriatrician in the Broadlawns Geriatric and Memory Center for his first three years with the Broadlawns. Prior to joining the medical staff at Broadlawns, he served as the Associate Dean of Global Health at Des Moines University and was the founding physician for the Des Moines University Memory Clinic.
Dr. Shah received his Doctor of Medicine degree from Bombay University in India. He completed his residency training in Family Medicine with the Mercy Mayo Residency Program, and he earned his Geriatric Fellowship from the Mayo Clinic where he worked on Mild Cognitive Impairment. He is triple-board-certified in Family Medicine, Geriatrics, Hospice and Palliative Care. Dr. Shah holds a Masters in Public Health from Des Moines University.
Dr. Shah has no actual or potential conflict of interest in relation to this program or presentation.
|
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Evaluation and Management
Original Program Date: 01/17/2025 |
|
The Truth Hurts: Misconceptions and Optimal Dermatologic Biopsy Technique for Diagnosis
Original Program Date: 01/17/2025 |
|
Expectations and Reality - Unraveling GLP-1 Agonists and Weight Loss
Original Program Date: 01/17/2025 |
|
Restorative Reproductive Medicine: A Better Way for Women’s Health
Original Program Date: 01/19/2025 |
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|